Recovery of Investment Losses involving Ampliphi Biosciences Corp.
The White Law Group is investigating potential securities claims involving broker-dealers who may have unsuitably recommended Ampliphi Biosciences Corp. to investors.
According to a press release on May 9, 2019, C3J Therapeutics, Inc. and AmpliPhi Biosciences Corporation merged into a new combined company, known as Armata Pharmaceuticals, Inc. The new company will focus on the development and advancement of phage-based therapeutic candidates to treat antibiotic-resistant infections. Armata is currently trading on the NYSE American stock exchange under the symbol “ARMP.”
AmpliPhi Biosciences Corporation reportedly filed a form D to raise capital from investors in 2015. The total offering amount was purportedly $13,000,000.